Science In Valuation
| SIS Stock | 27.00 0.50 1.89% |
At this time, the company appears to be overvalued. Science in Sport has a current Real Value of USD21.84 per share. The regular price of the company is USD27.0. Our model measures the value of Science in Sport from inspecting the company fundamentals such as Return On Equity of -0.33, shares outstanding of 230.23 M, and Operating Margin of (0.07) % as well as reviewing its technical indicators and probability of bankruptcy.
Price Book 2.3381 | Enterprise Value 73.7 M | Enterprise Value Ebitda (8.49) | Price Sales 1.1525 | Enterprise Value Revenue 1.3669 |
Overvalued
Today
Please note that Science In's price fluctuation is very steady at this time. Calculation of the real value of Science in Sport is based on 3 months time horizon. Increasing Science In's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Science stock is determined by what a typical buyer is willing to pay for full or partial control of Science in Sport. Since Science In is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Science Stock. However, Science In's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 27.0 | Real 21.84 | Hype 27.0 |
The real value of Science Stock, also known as its intrinsic value, is the underlying worth of Science in Sport Company, which is reflected in its stock price. It is based on Science In's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Science In's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Science in Sport helps investors to forecast how Science stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Science In more accurately as focusing exclusively on Science In's fundamentals will not take into account other important factors: Science In Cash |
|
Science In Total Value Analysis
Science in Sport is at this time forecasted to have takeover price of 73.73 M with market capitalization of 62.16 M, debt of 23.85 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Science In fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
73.73 M | 62.16 M | 23.85 M |
Science In Investor Information
About 17.0% of the company outstanding shares are owned by corporate insiders. The book value of Science In was at this time reported as 0.15. The company recorded a loss per share of 0.06. Science in Sport had not issued any dividends in recent years. The entity had 1572:1571 split on the 14th of November 2017. Based on the analysis of Science In's profitability, liquidity, and operating efficiency, Science in Sport is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Science In Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Science In has an asset utilization ratio of 89.15 percent. This indicates that the Company is making USD0.89 for each dollar of assets. An increasing asset utilization means that Science in Sport is more efficient with each dollar of assets it utilizes for everyday operations.Science In Ownership Allocation
Science in Sport shows a total of 230.23 Million outstanding shares. Over half of Science In's outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Science in Sport. Please watch out for any change in the institutional holdings of Science In as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Science In Profitability Analysis
The company reported the revenue of 62.67 M. Net Loss for the year was (11.28 M) with profit before overhead, payroll, taxes, and interest of 26.94 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Science In's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Science In and how it compares across the competition.
About Science In Valuation
The stock valuation mechanism determines Science In's current worth on a weekly basis. Our valuation model uses a comparative analysis of Science In. We calculate exposure to Science In's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Science In's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 26.8 M | 15.3 M |
Complementary Tools for Science Stock analysis
When running Science In's price analysis, check to measure Science In's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Science In is operating at the current time. Most of Science In's value examination focuses on studying past and present price action to predict the probability of Science In's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Science In's price. Additionally, you may evaluate how the addition of Science In to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |